HCA Healthcare (NYSE:HCA) had its target price upped by Argus from $150.00 to $155.00 in a report issued on Tuesday morning, MarketBeat Ratings reports. They currently have a buy rating on the stock.

Other equities research analysts also recently issued research reports about the stock. Jefferies Financial Group restated a buy rating and issued a $135.00 target price on shares of HCA Healthcare in a research note on Thursday, July 26th. SunTrust Banks boosted their target price on shares of HCA Healthcare to $145.00 and gave the company a buy rating in a research note on Thursday, July 26th. Cantor Fitzgerald restated a buy rating and issued a $115.00 target price on shares of HCA Healthcare in a research note on Friday, July 20th. ValuEngine upgraded shares of HCA Healthcare from a hold rating to a buy rating in a research note on Wednesday, July 18th. Finally, Zacks Investment Research upgraded shares of HCA Healthcare from a hold rating to a buy rating and set a $119.00 target price on the stock in a research note on Monday, July 16th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the company. The stock currently has an average rating of Buy and an average price target of $141.53.

HCA traded up $2.32 during trading on Tuesday, reaching $143.95. 1,903,245 shares of the company’s stock were exchanged, compared to its average volume of 2,252,907. HCA Healthcare has a fifty-two week low of $74.26 and a fifty-two week high of $144.18. The company has a market capitalization of $48.75 billion, a P/E ratio of 21.84, a P/E/G ratio of 1.24 and a beta of 0.48.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.93 by $0.23. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The firm had revenue of $11.45 billion for the quarter, compared to the consensus estimate of $11.29 billion. During the same quarter in the previous year, the company earned $1.13 earnings per share. The business’s revenue was up 7.1% compared to the same quarter last year. On average, analysts forecast that HCA Healthcare will post 9.35 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 28th. Investors of record on Monday, December 3rd will be issued a $0.35 dividend. The ex-dividend date is Friday, November 30th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 0.97%. HCA Healthcare’s dividend payout ratio is 21.24%.

In other HCA Healthcare news, insider Michael S. Cuffe sold 4,943 shares of the business’s stock in a transaction dated Friday, November 9th. The stock was sold at an average price of $141.90, for a total transaction of $701,411.70. Following the completion of the sale, the insider now directly owns 33,240 shares of the company’s stock, valued at approximately $4,716,756. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Jane D. Englebright sold 6,543 shares of the business’s stock in a transaction dated Wednesday, August 15th. The stock was sold at an average price of $129.86, for a total value of $849,673.98. Following the sale, the senior vice president now directly owns 7,443 shares of the company’s stock, valued at $966,547.98. The disclosure for this sale can be found here. Insiders sold 22,486 shares of company stock valued at $3,079,086 over the last ninety days. 2.80% of the stock is currently owned by company insiders.

A number of large investors have recently made changes to their positions in the business. FMR LLC raised its holdings in HCA Healthcare by 98.7% during the 3rd quarter. FMR LLC now owns 10,907,407 shares of the company’s stock worth $1,517,438,000 after purchasing an additional 5,419,134 shares during the last quarter. LSV Asset Management raised its holdings in HCA Healthcare by 0.3% during the 3rd quarter. LSV Asset Management now owns 5,474,392 shares of the company’s stock worth $761,597,000 after purchasing an additional 15,004 shares during the last quarter. Northern Trust Corp raised its holdings in HCA Healthcare by 4.2% during the 2nd quarter. Northern Trust Corp now owns 3,460,267 shares of the company’s stock worth $355,023,000 after purchasing an additional 138,135 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in HCA Healthcare by 15.6% during the 3rd quarter. Bank of New York Mellon Corp now owns 2,406,809 shares of the company’s stock worth $334,834,000 after purchasing an additional 324,724 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA raised its holdings in HCA Healthcare by 98.3% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,767,715 shares of the company’s stock worth $245,925,000 after purchasing an additional 876,226 shares during the last quarter. 70.84% of the stock is owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: How Investors Use a Balance Sheet

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.